These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27036989)

  • 1. Is sub-Saharan Africa ready for pre-exposure prophylaxis?
    Bernier A; Gapiya J; Sylla A; Anoma C; Somda M; Dah E; Aranda JF; Himmich H
    Lancet HIV; 2016 Apr; 3(4):e154-5. PubMed ID: 27036989
    [No Abstract]   [Full Text] [Related]  

  • 2. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
    Ebell MH
    Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839
    [No Abstract]   [Full Text] [Related]  

  • 3. Better late than never: PrEP in England.
    The Lancet Hiv
    Lancet HIV; 2017 Jan; 4(1):e1. PubMed ID: 28007341
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-exposure prophylaxis is effective at preventing HIV in high risk gay men, study shows.
    Mayor S
    BMJ; 2015 Sep; 351():h4860. PubMed ID: 26359448
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks and benefits HIV preexposure prophylaxis with tenofovir/emtricitabine in an older male with comorbidities.
    Girometti N; Jones R; Levy J; McCormack S; Sullivan A; Barber TJ
    AIDS; 2016 Aug; 30(13):2131-3. PubMed ID: 27219131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to "PrEP" for HIV Prevention in Women.
    Ntim GJ; Kransdorf LN
    J Womens Health (Larchmt); 2017 Feb; 26(2):195-196. PubMed ID: 28140756
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantification of tenofovir disoproxil fumarate and emtricitabine in generic pre-exposure prophylaxis tablets obtained from the internet.
    Wang X; Nutland W; Brady M; Green I; Boffito M; McClure M
    Int J STD AIDS; 2019 Jul; 30(8):765-768. PubMed ID: 31072205
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.
    Mugo PM; Sanders EJ; Mutua G; van der Elst E; Anzala O; Barin B; Bangsberg DR; Priddy FH; Haberer JE
    AIDS Behav; 2015 May; 19(5):794-801. PubMed ID: 25432877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.
    Mugwanya KK; Baeten JM
    Expert Opin Drug Saf; 2016; 15(2):265-73. PubMed ID: 26634852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Welcome to the preexposure prophylaxis revolution.
    Baeten J; McCormack S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):1-2. PubMed ID: 26633637
    [No Abstract]   [Full Text] [Related]  

  • 11. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention.
    Rowan SE; Patel RR; Schneider JA; Smith DK
    Lancet HIV; 2021 Feb; 8(2):e114-e120. PubMed ID: 33128874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis.
    Haaland RE; Martin A; Holder A; Fountain JJ; Hall L; Pescatore NA; Heeke S; Kelley CF
    AIDS; 2017 Jul; 31(11):1647-1650. PubMed ID: 28657968
    [No Abstract]   [Full Text] [Related]  

  • 13. UK PrEP decision re-ignites HIV activism.
    The Lancet
    Lancet; 2016 Apr; 387(10027):1484. PubMed ID: 27115959
    [No Abstract]   [Full Text] [Related]  

  • 14. Pre-exposure Prophylaxis Therapy and the Blood-Brain Barrier: Is PrEP Neuroprotective?
    Kettlewell J; Barney M; Oda R; Agsalda-Garcia M; Siriwardhana C; Shiramizu B
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):10-12. PubMed ID: 31828733
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men.
    Seifert SM; Glidden DV; Meditz AL; Castillo-Mancilla JR; Gardner EM; Predhomme JA; Rower C; Klein B; Kerr BJ; Guida LA; Zheng JH; Bushman LR; Anderson PL
    Clin Infect Dis; 2015 Mar; 60(5):804-10. PubMed ID: 25409469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of M184V mutant human immunodeficiency virus in a patient using daily pre-exposure prophylaxis.
    Jewsbury S; Ward C
    Int J STD AIDS; 2020 Jan; 31(1):85-87. PubMed ID: 31801029
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV Prevention: Opportunities and Challenges.
    Marrazzo JM
    Top Antivir Med; 2017; 24(4):123-126. PubMed ID: 28208119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure prophylaxis failure with tenofovir disoproxil.
    Streeck H; Verheyen J; Storim J; Dittmer U; Jochum C; Timm J; Esser S
    AIDS; 2017 Jan; 31(1):176-177. PubMed ID: 27898596
    [No Abstract]   [Full Text] [Related]  

  • 19. Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19.
    Quirke S; Quinn L; Hegarty D; Loy A; Lyons F; Mulcahy F; Devitt E
    Int J STD AIDS; 2021 Jan; 32(1):100-103. PubMed ID: 33050787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral preexposure prophylaxis to prevent HIV infection: clinical and public health implications.
    Baker J; OʼHara KM
    JAAPA; 2014 Dec; 27(12):10-7. PubMed ID: 25390822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.